CFTR: New insights into structure and function and implications for modulation by small molecules
- PMID: 31759907
- DOI: 10.1016/j.jcf.2019.10.021
CFTR: New insights into structure and function and implications for modulation by small molecules
Abstract
Structural biology and functional studies are a powerful combination to elucidate fundamental knowledge about the cystic fibrosis transmembrane conductance regulator (CFTR). Here, we discuss the latest findings, including how clinically-approved drugs restore function to mutant CFTR, leading to better clinical outcomes for people with cystic fibrosis (CF). Despite the prospect of regulatory approval of a CFTR-targeting therapy for most CF mutations, strenuous efforts are still needed to fully comprehend CFTR structure-and-function for the development of better drugs to enable people with CF to live full and active lives.
Keywords: ABC-transporter; Clinical drugs; Cystic fibrosis; F508del; Membrane protein; Mutations; Therapy.
Copyright © 2019. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest DNS is the recipient of a Vertex Innovation Award, IS-G is the recipient of two Vertex Innovation Awards and a member of the scientific boards of Eloxx, PTC Therapeutics and Vertex Therapeutics. T-CH has an ongoing service agreement with Abbvie and a sponsored research grant from Nanova.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
